pegloticase  - Drug Details
📊 Estimates pegloticase  Dialyzability By Different_Modalities

pegloticase 

Complete Drug Information

Drug Name
pegloticase 
Trade Names
Krystexxa, Puricase
Bioavailability
N/A
Routes of Administration
Intravenous infusion
Elimination
10–12 days
Formula
C1549H2430N408O448S8
Molar Mass
34193.37
Volume of Distribution
C1549H2430N408O448S8